CI
The Cigna Group
NYSE · Healthcare · Medical - Healthcare Plans · US
$298.50
−1.26%Year over year
Reported trailing growth
- Revenue
- +7.7%
- EBITDA
- +1.9%
- EBIT
- +6.6%
- EPS
- +31.7%
- Free cash flow
- +131.1%
- Operating cash flow
- +94.2%
Forward estimates
Based on analyst estimates
- Revenue
- +4.9%
- EBITDA
- +17.6%
- EPS
- +34.7%
Three-year CAGR
- Revenue
- +15.1%
- EBITDA
- +0.7%
- EBIT
- +2.6%
- Net income
- -3.9%
- EPS
- +1.0%
- Free cash flow
- +4.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026